Active Premix for Antiperspirant Products Patent Application
Summary
The USPTO published patent application US20260096962A1 covering a particulate active premix composition for antiperspirant products. The composition combines basic aluminum chloride of formula Al2(OH)3.778Cl2.222 to Al2(OH)5.048Cl0.952, an amino acid, an alkaline earth metal salt, and greater than 1% of an alkali metal salt and/or magnesium chloride. Inventors: Wade Charles Henke, Shawn David McConaughy, and David Frederick Swain.
What changed
The USPTO published patent application US20260096962A1 for a particulate active premix composition for antiperspirant products. The composition comprises basic aluminum chloride within a specified formula range, an amino acid, an alkaline earth metal salt, and greater than 1% of an alkali metal salt and/or magnesium chloride. Inventors: Wade Charles Henke, Shawn David McConaughy, and David Frederick Swain.
This publication grants the applicants exclusive IP rights to the described antiperspirant active premix. It does not create compliance obligations for other parties but may be relevant for manufacturers developing similar antiperspirant formulations who should assess potential freedom-to-operate considerations.
What to do next
- Monitor for updates
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ACTIVE PREMIX FOR ANTIPERSPIRANT PRODUCTS
Application US20260096962A1 Kind: A1 Apr 09, 2026
Inventors
Wade Charles HENKE, Shawn David MCCONAUGHY, David Frederick SWAILE
Abstract
A particulate active premix composition that includes basic aluminum chloride of formula Al2(OH)3.778Cl2.222 to Al2(OH)5.048Cl0.952, an amino acid, an alkaline earth metal salt, and greater than 1% of an alkali metal salt and/or magnesium chloride. The composition can be a particle. The particulate active premix can be incorporated into antiperspirant products.
CPC Classifications
A61K 8/26 A61K 8/046 A61K 8/20 A61K 8/44 A61Q 15/00
Filing Date
2025-10-03
Application No.
19349072
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.